Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 1, 2011, Pages 40-52

  Dhillon, Navneet K ^a   Li, Fang ^a,d   Xue, Bing ^a   Tawfik, Ossama ^a   Morgello, Susan ^b   Buch, Shilpa ^c   Ladner, Amy O'Brien ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Platelet derived growth factor; Tight junction proteins; Trans activator of transcription; Vascular remodeling

Indexed keywords

COCAINE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

ADULT; ARTERY DISEASE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; MACROPHAGE; MALE; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; UPREGULATION;

ANESTHETICS, LOCAL; CELLS, CULTURED; COCAINE; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; HYPERTENSION, PULMONARY; LUNG; MACROPHAGES; MUSCLE, SMOOTH; PLATELET-DERIVED GROWTH FACTOR; RESPIRATORY MUCOSA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80051571883     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0097OC     Document Type: Article

References (72)

1. Barbaro G. Cardiovascular manifestations of HIV infection. J R Soc Med 2001;94:384-390. (Pubitemid 32738677)
2. Barbaro G, Lipshultz SE. Pathogenesis of HIV-associated cardiomyopathy. Ann N Y Acad Sci 2001;946:57-81. (Pubitemid 33127209)
3. Bauersachs J, Bouloumie A, Fraccarollo D, Hu K, Busse R, Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 1999;100:292-298. (Pubitemid 29340137)
4. Kitayama J, Faraci FM, Lentz SR, Heistad DD. Cerebral vascular dysfunction during hypercholesterolemia. Stroke 2007;38:2136-2141. (Pubitemid 47012280)
5. Dobbs MR, Berger JR. Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther 2009;7:1263-1271.
6. Humbert M, Montani D, Perros F, Dorfmuller P, Adnot S, Eddahibi S. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vascul Pharmacol 2008;49:113-118.
7. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43(12, Suppl S)13S-24S. (Pubitemid 38759713)
8. Degano B, GuillaumeM, Savale L,Montani D, Jais X, Yaici A, Le Pavec J, Humbert M, Simonneau G, Sitbon O. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS 2010;24:67-75.
9. Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension in HIV infection. Chest 1991;100:1268-1271.
10. Reinsch N, Buhr C, Krings P, Kaelsch H, Kahlert P, Konorza T, Neumann T, Erbel R. Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study. HIV Med 2008;9:550-556.
11. Sitbon O, Lascoux-Combe C, Delfraissy JF, Yeni PG, Raffi F, De Zuttere D, Gressin V, Clerson P, Sereni D, Simonneau G. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 2008;177:108-113.
12. Byers DK, Nayak G, Ferguson M. Prevalence of pulmonary hypertension in asymptomatic HIV-infected pateints receiving antiretroviral therapy [abstract]. Washington, D.C.: 48th Annual International Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Abstract H-2312.
13. Hsue PY, Deeks SG, Farah HH, Palav S, Ahmed SY, Schnell A, Ellman AB, Huang L, Dollard SC, Martin JN. Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS 2008;22:825-833. (Pubitemid 351563831)
14. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 2000;118:1133-1141.
15. Opravil M, Sereni D. Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era. AIDS 2008;22: S35-S40.
16. Nunes H, Humbert M, Sitbon O, Morse JH, Deng Z, Knowles JA, Le Gall C, Parent F, Garcia G, Herve P, et al. Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2003;167:1433-1439. (Pubitemid 36609730)
17. Collazos J, Martinez E, Fernandez A,Mayo J. Acute, reversible pulmonary hypertension associated with cocaine use. Respir Med 1996;90:171-174. (Pubitemid 26146404)
18. Yakel DL Jr, Eisenberg MJ. Pulmonary artery hypertension in chronic intravenous cocaine users. Am Heart J 1995;130:398-399.
19. Chin KM, Channick RN, Rubin LJ. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Chest 2006;130: 1657-1663. (Pubitemid 46033416)
20. Schaiberger PH, Kennedy TC, Miller FC, Gal J, Petty TL. Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine. Chest 1993;104:614-616. (Pubitemid 23229544)
21. Dhillon NK, Peng F, Bokhari S, Callen S, Shin SH, Zhu X, Kim KJ, Buch SJ. Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2/CCR2 axis across the blood-brain barrier: implications for HIV-dementia. J Neuroimmune Pharmacol 2008;3:52-56.
22. Zhong Y, Smart EJ, Weksler B, Couraud PO, Hennig B, Toborek M. Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J Neurosci 2008;28:7788-7796.
23. Persidsky Y, Heilman D, Haorah J, Zelivyanskaya M, Persidsky R, Weber GA, Shimokawa H, Kaibuchi K, Ikezu T. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 2006;107: 4770-4780. (Pubitemid 43882628)
24. Kanmogne GD, Primeaux C, Grammas P. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol 2005;64:498-505. (Pubitemid 40781152)
25. Dhillon NK, Williams R, Peng F, Tsai YJ, Dhillon S, Nicolay B, Gadgil M, Kumar A, Buch SJ. Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia. J Neurovirol 2007;13:483-495.
26. Balasubramaniam V, Le Cras TD, Ivy DD, Grover TR, Kinsella JP, Abman SH. Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 2003;284:L826-L833. (Pubitemid 36459029)
27. Fukuda N, Kishioka H, Satoh C, Nakayama T, Watanabe Y, Soma M, Izumi Y, Kanmatsuse K. Role of long-form PDGF A-chain in the growth of vascular smooth muscle cells from spontaneously hypertensive rats. Am J Hypertens 1997;10:1117-1124. (Pubitemid 27488578)
28. Humbert M, Monti G, Fartoukh M, Magnan A, Brenot F, Rain B, Capron F, Galanaud P, Duroux P, Simonneau G, et al. Plateletderived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 1998;11:554-559. (Pubitemid 28194842)
29. Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, et al. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2008; 178:81-88. (Pubitemid 351919196)
30. Dhillon NK, Sui Y, Pinson D, Li S, Dhillon S, Tawfik O, Callen S, Nemon O, Narayan O, Buch S. Upregulation of expression of platelet-derived growth factor and its receptor in pneumonia associated with SHIVinfected macaques. AIDS 2007;21:307-316. (Pubitemid 46175043)
31. Potula R, Dhillion N, Sui Y, Zien CA, Funa K, Pinson D, Mayo MS, Singh DK, Narayan O, Buch S. Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am J Pathol 2004;165:815-824. (Pubitemid 39129289)
32. Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 2005;353:1412-1413. (Pubitemid 41362714)
33. Patterson KC, Weissmann A, Ahmadi T, Farber HW. Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Ann Intern Med 2006;145:152-153. (Pubitemid 46780594)
34. Souza R, Sitbon O, Parent F, Simonneau G, Humbert M. Long term imatinib treatment in pulmonary arterial hypertension. Thorax 2006; 61:736. (Pubitemid 44211786)
35. Helland DE, Welles JL, Caputo A, Haseltine WA. Transcellular transactivation by the human immunodeficiency virus type 1 Tat protein. J Virol 1991;65:4547-4549.
36. Marcuzzi A, Weinberger J, Weinberger OK. Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. J Virol 1992;66:4228-4232.
37. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993;67:277-287. (Pubitemid 23002988)
38. Barillari G, Ensoli B. Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev 2002;15:310-326. (Pubitemid 34303768)
39. Kim CM, Vogel J, Jay G, Rhim JS. The HIV Tat gene transforms human keratinocytes. Oncogene 1992;7:1525-1529.
40. Corallini A, Campioni D, Rossi C, Albini A, Possati L, Rusnati M, Gazzanelli G, Benelli R, Masiello L, Sparacciari V, et al. Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/Tat transgenic mice. AIDS 1996;10:701-710. (Pubitemid 26172772)
41. Corallini A, Altavilla G, Pozzi L, Bignozzi F, Negrini M, Rimessi P, Gualandi F, Barbanti-Brodano G. Systemic expression of HIV-1 Tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 1993;53:5569-5575. (Pubitemid 23342186)
42. Kundu RK, Sangiorgi F, Wu LY, Pattengale PK, Hinton DR, Gill PS, Maxson R. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood 1999;94:275-282. (Pubitemid 29300159)
43. Dhillon NK, Peng F, Ransohoff RM, Buch S. PDGF synergistically enhances IFN-gamma-induced expression of CXCL10 in blood-derived macrophages: implications for HIV dementia. J Immunol 2007; 179:2722-2730.
44. Sui Y, Potula R, Pinson D, Adany I, Li Z, Day J, Buch E, Segebrecht J, Villinger F, Liu Z, et al. Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis. J Med Primatol 2003;32:229-239. (Pubitemid 37021248)
45. Rosenberg HC, Rabinovitch M. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol 1988;255:H1484-H1491.
46. Andras IE, Pu H, Deli MA, Nath A, Hennig B, Toborek M. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res 2003;74:255-265. (Pubitemid 37193712)
47. Hansmann G, de Jesus Perez VA, Alastalo TP, Alvira CM, Guignabert C, Bekker JM, Schellong S, Urashima T, Wang L, Morrell NW, et al. An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 2008;118:1846-1857. (Pubitemid 351632387)
48. Sandler C, Joutsiniemi S, Lindstedt KA, Juutilainen T, Kovanen PT, Eklund KK. Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 2006;347:31-35. (Pubitemid 44015645)
49. Park J, Kim S, Oh JK, Kim JY, Yoon SS, Lee D, Kim Y. Identification of differentially expressed proteins in imatinib mesylate-resistant chronic myelogenous cells. J Biochem Mol Biol 2005;38:725-738. (Pubitemid 43240979)
50. Vuorinen K, Gao F, Oury TD, Kinnula VL, Myllarniemi M. Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia. Exp Lung Res 2007;33:357-373. (Pubitemid 47396405)
51. Dudley A, Gilbert RE, Thomas D, Cox A, Price JT, Best J, Jenkins A. STI-571 inhibits in vitro angiogenesis. Biochem Biophys Res Commun 2003;310:135-142. (Pubitemid 37162773)
52. Mette SA, Palevsky HI, Pietra GG, Williams TM, Bruder E, Prestipino AJ, Patrick AM, Wirth JA. Primary pulmonary hypertension in association with human immunodeficiency virus infection: a possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis 1992;145:1196-1200.
53. Kanmogne GD, Kennedy RC, Grammas P. Analysis of human lung endothelial cells for susceptibility to HIV type 1 infection, coreceptor expression, and cytotoxicity of gp120 protein. AIDS Res Hum Retroviruses 2001;17:45-53. (Pubitemid 32098007)
54. Klings ES, Farber HW. The pathogenesis of HIV-associated pulmonary hypertension. Adv Cardiol 2003;40:71-82.
55. Pellicelli AM, D'Ambrosio C, Vizza CD, Borgia MC, Tanzi P, Pino P, Zachara E, Soccorsi F. HIV-related pulmonary hypertension: from pathogenesis to clinical aspects. Acta Cardiol 2004;59:323-330. (Pubitemid 38787601)
56. Voelkel NF, Tuder RM. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 1995;8: 2129-2138.
57. Humbert M. Mediators involved in HIV-related pulmonary arterial hypertension. AIDS 2008;22:S41-S47.
58. Marecki JC, Cool CD, Parr JE, Beckey VE, Luciw PA, Tarantal AF, Carville A, Shannon RP, Cota-Gomez A, Tuder RM, et al. HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIVNef-infected macaques. Am J Respir Crit Care Med 2006;174:437-445. (Pubitemid 44223125)
59. Ehrenreich H, Rieckmann P, Sinowatz F, Weih KA, Arthur LO, Goebel FD, Burd PR, Coligan JE, Clouse KA. Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Immunol 1993;150:4601-4609. (Pubitemid 23133737)
60. Kanmogne GD, Primeaux C, Grammas P. Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. Biochem Biophys Res Commun 2005;333: 1107-1115. (Pubitemid 40910118)
61. Voelkel NF, Cool CD, Flores S. From viral infection to pulmonary arterial hypertension: a role for viral proteins? AIDS 2008;22:S49-S53.
62. Lotz M, Clark-Lewis I, Ganu V. HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. J Cell Biol 1994;124:365-371. (Pubitemid 24050354)
63. Del Sorbo L, Arese M, Giraudo E, Tizzani M, Biancone L, Bussolino F, Camussi G. Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. Eur J Immunol 2001;31: 376-383. (Pubitemid 32166591)
64. Park IW, Ullrich CK, Schoenberger E, Ganju RK, Groopman JE. HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. J Immunol 2001;167:2766-2771. (Pubitemid 32768908)
65. Toschi E, Barillari G, Sgadari C, Bacigalupo I, Cereseto A, Carlei D, Palladino C, Zietz C, Leone P, Sturzl M, et al. Activation of matrixmetalloproteinase- 2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Mol Biol Cell 2001;12:2934-2946. (Pubitemid 33062952)
66. Wu RF, Gu Y, Xu YC, Mitola S, Bussolino F, Terada LS. Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. J Virol 2004;78:779-789. (Pubitemid 38067600)
67. Gan X, Zhang L, Berger O, Stins MF, Way D, Taub DD, Chang SL, Kim KS, House SD, Weinand M, et al. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin Immunol 1999;91: 68-76.
68. Fiala M, Gan XH, Zhang L, House SD, Newton T, Graves MC, Shapshak P, Stins M, Kim KS, Witte M, et al. Cocaine enhances monocyte migration across the blood-brain barrier: cocaine's connection to AIDS dementia and vasculitis? Adv Exp Med Biol 1998;437: 199-205. (Pubitemid 28350097)
69. Chang SL, Bersig J, Felix B, Fiala M, House SD. Chronic cocaine alters hemodynamics and leukocyte-endothelial interactions in rat mesenteric venules. Life Sci 2000;66:2357-2369. (Pubitemid 30252324)
70. Rabinovitch M, Bothwell T, Hayakawa BN, Williams WG, Trusler GA, Rowe RD, Olley PM, Cutz E. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension: a correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest 1986;55:632-653. (Pubitemid 17231129)
71. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, Yuan JX. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol 2003;284:C316-C330. (Pubitemid 36120070)
72. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995;151: 1628-1631.